New aprepitant suspension for use in children

Emend (aprepitant) is now available as a powder for oral suspension, allowing use of the neurokinin NK1 antagonist in children aged 6 months and over.

Licensed for the prevention of nausea and vomiting associated with highly and moderately emetogenic chemotherapy, the oral suspension can be prescribed for children aged 6 months to 11 years weighing at least 6kg. The recommended dose is based on body weight and should be administered one hour before chemotherapy on days 1, 2 and 3 or in the morning on days 2 and 3 if no chemotherapy is being given.

The oral suspension is supplied as 125mg powder in a sachet to provide a 125mg/5ml oral suspension after reconstitution. Emend capsules containing 80mg or 125mg aprepitant remain available for adults and adolescents.

MIMS Clinics

Prescribing news and resources for key therapeutic areas, collated by the MIMS editors.

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS bulletins

News and updates straight to your inbox.

Prescribing Update: Fortnightly news bulletin
Urgent prescribing updates
Spotlight: Disease-themed monthly round-up

Sign me up

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases

Promo Image

Clinical calculators

Handy calculators and conversions for primary care.